TARGETING STEM CELLS: The Energesis team, including senior scientist Scott Gullicksen (left), CSO and cofounder Olivier Boss (center), and COO and cofounder Brian Freeman, is targeting human brown adipocyte stem cells (bottom, after differentiation into brown adipocytes) to search for novel obesity drug targets.